SUBLOCADE

This brand name is authorized in Australia, Canada, Israel, New Zealand, United States

Active ingredients

The drug SUBLOCADE contains one active pharmaceutical ingredient (API):

1 Buprenorphine UNII 40D3SCR4GZ - BUPRENORPHINE

Buprenorphine is an opioid partial agonist/antagonist which attaches itself to the μ (mu) and κ (kappa) receptors of the brain. Its activity in opioid maintenance treatment is attributed to its slowly reversible link with the μ receptors which, over a prolonged period, minimises the need of illicit opioids for patients with opioid dependence. Read about Buprenorphine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SUBLOCADE Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N07BC01	Buprenorphine	N Nervous system → N07 Other nervous system drugs → N07B Drugs used in addictive disorders → N07BC Drugs used in opioid dependence
Discover more medicines within N07BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11987X, 11990C
Country: CA	Health Products and Food Branch	Identifier(s): 02483084, 02483092
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8629, 8630
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 20364, 20390
Country: US	FDA, National Drug Code	Identifier(s): 12496-0100, 12496-0300